Radiotherapy after mastectomy for women with one to three positive nodes significantly reduces the risk of recurrence and breast cancer mortality, researchers found in a meta-analysis.
With...
TAMPA – Women with BRCA1 mutations who undergo risk-reducing salpingo-oophorectomy may remain at risk for rare types of aggressive uterine cancer, according to preliminary findings from a prospective...
A noninvasive, multitarget stool DNA test detected significantly more cancer than did a fecal immunochemical test in people at average risk for colorectal cancer, but had greater false positive...
WASHINGTON – Several dozen organizations have joined together to help increase colorectal cancer screening rates to 80% of all Americans by 2018, citing the success of campaigns over the past decade...
An adnexal mass is a common gynecological presentation that can affect women of all ages. Typically, the mass is identified during an annual pelvic exam or incidentally when patients undergo pelvic...
An immunomodulator that targets the PD-1 pathway effected sustained remission in 31% of patients who took it for advanced melanoma.
Remission lasted a median of 2 years, with 1- and 2-year overall...
Hormone therapy was associated with improved overall survival in women with non–small-cell lung carcinoma, reported investigators in the March issue of the Journal of Thoracic Oncology.
Long-term...
Endoscopic resection for mucosal esophageal adenocarcinoma is safe and highly effective, and should be the new standard of care.
That’s according to Dr. Oliver Pech, whose study in the March issue...
Current evidence is still insufficient to adequately assess whether taking vitamin supplements to prevent cardiovascular disease or cancer is beneficial or harmful, <link...
BRUSSELS – National Cancer Institute Director Catherine Alfano, Ph.D., summarizes the institute’s work on improving cancer survivor planning, better coordinating survivor care, and gathering new data...
